Does VERTEPORFIN Cause Product use in unapproved indication? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Product use in unapproved indication have been filed in association with VERTEPORFIN (Visudyne). This represents 7.6% of all adverse event reports for VERTEPORFIN.
57
Reports of Product use in unapproved indication with VERTEPORFIN
7.6%
of all VERTEPORFIN reports
1
Deaths
1
Hospitalizations
How Dangerous Is Product use in unapproved indication From VERTEPORFIN?
Of the 57 reports, 1 (1.8%) resulted in death, 1 (1.8%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VERTEPORFIN. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does VERTEPORFIN Cause?
Visual acuity reduced (173)
Off label use (129)
Polypoidal choroidal vasculopathy (128)
Disease progression (115)
Age-related macular degeneration (90)
Retinal haemorrhage (70)
Choroidal neovascularisation (47)
Retinal detachment (42)
Subretinal fluid (42)
Detachment of retinal pigment epithelium (36)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which VERTEPORFIN Alternatives Have Lower Product use in unapproved indication Risk?
VERTEPORFIN vs VESICARE
VERTEPORFIN vs VFEND
VERTEPORFIN vs VIAGRA
VERTEPORFIN vs VIBEGRON
VERTEPORFIN vs VICODIN